Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

Dow Jones04-29

By Aimee Look

Haleon booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste.

The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%.

Reported revenue rose 0.1% to 2.86 billion pounds ($3.87 billion).

The U.K. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said.

The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was "tempered by a weak cold and flu season," Chief Executive Officer Brian McNamara said.

Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Meanwhile, revenue for its respiratory health category fell 3.4% over the same period on an organic basis.

Revenue in North America rose 1% on an organic basis to 932 million pounds, returning to growth despite a weak cold and flu season.

The company said it expects organic revenue growth of 3% to 5% for the full year.

Write to Aimee Look at aimee.look@wsj.com

(END) Dow Jones Newswires

April 29, 2026 03:33 ET (07:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2631564669?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 15:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631564669","market":"nz","top_or_hot":-1,"title":"Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Aimee Look \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/HLN\">Haleon</a> booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste. \n</p>\n<p>\n  The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%. \n</p>\n<p>\n  Reported revenue rose 0.1% to 2.86 billion pounds ($3.87 billion). \n</p>\n<p>\n  The U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said. \n</p>\n<p>\n  The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was \"tempered by a weak cold and flu season,\" Chief Executive Officer Brian McNamara said. \n</p>\n<p>\n  Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Meanwhile, revenue for its respiratory health category fell 3.4% over the same period on an organic basis. \n</p>\n<p>\n  Revenue in North America rose 1% on an organic basis to 932 million pounds, returning to growth despite a weak cold and flu season. \n</p>\n<p>\n  The company said it expects organic revenue growth of 3% to 5% for the full year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Aimee Look at aimee.look@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 29, 2026 03:33 ET (07:33 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-29 15:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Aimee Look \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/HLN\">Haleon</a> booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste. \n</p>\n<p>\n  The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%. \n</p>\n<p>\n  Reported revenue rose 0.1% to 2.86 billion pounds ($3.87 billion). \n</p>\n<p>\n  The U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said. \n</p>\n<p>\n  The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was \"tempered by a weak cold and flu season,\" Chief Executive Officer Brian McNamara said. \n</p>\n<p>\n  Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Meanwhile, revenue for its respiratory health category fell 3.4% over the same period on an organic basis. \n</p>\n<p>\n  Revenue in North America rose 1% on an organic basis to 932 million pounds, returning to growth despite a weak cold and flu season. \n</p>\n<p>\n  The company said it expects organic revenue growth of 3% to 5% for the full year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Aimee Look at aimee.look@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 29, 2026 03:33 ET (07:33 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HLN","symbol_name":"Haleon","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2631564669","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631564669","pubTimestamp":1777447980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Haleon booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste.The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%.Reported revenue rose 0.1% to 2.86 billion pounds .The U.K. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said.The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was \"tempered by a weak cold and flu season,\" Chief Executive Officer Brian McNamara said.Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Mea","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HLN":"Haleon"},"translate_title":"舒适达制造商Haleon收入因口腔健康增长而增长——更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLN":1.5},"content_text":"By Aimee Look \n\n\n \n\n\nHaleon booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste. \n\n\n  The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%. \n\n\n  Reported revenue rose 0.1% to 2.86 billion pounds ($3.87 billion). \n\n\n  The U.K. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said. \n\n\n  The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was \"tempered by a weak cold and flu season,\" Chief Executive Officer Brian McNamara said. \n\n\n  Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Meanwhile, revenue for its respiratory health category fell 3.4% over the same period on an organic basis. \n\n\n  Revenue in North America rose 1% on an organic basis to 932 million pounds, returning to growth despite a weak cold and flu season. \n\n\n  The company said it expects organic revenue growth of 3% to 5% for the full year. \n\n\n \n\n\n  Write to Aimee Look at aimee.look@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2026 03:33 ET (07:33 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2631564669","isCrawlerRequest":true}